Cabaluna, Bb Boy A.

HRN: 212277  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2022
AMPICILLIN 250MG (VIAL)
04/24/2022
04/30/2022
IV
150mg
Q12H
PSNB
04/24/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/24/2022
04/30/2022
IV
45mg
Q24H
PSNB
Waiting Final Action 
04/27/2022
AMPICILLIN 500MG (VIAL)
04/27/2022
04/30/2022
IV
150 Mg
Q12h
Neinatal Pneumonia
04/27/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/27/2022
04/29/2022
IV
45mg
Q24h
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: